Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment [NA]
An update on a completed clinical trial focused on building an outcomes assessment infrastructure for evaluating anxiety treatments. Sponsor…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Psilocybin for Treatment of OCD-2 [Phase 1, Phase 2]
A clinical trial update indicates a Phase 1/Phase 2 study evaluating psilocybin for treatment of obsessive-compulsive disorder, sponsored by…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD [NA]
A University of Pennsylvania-led clinical trial is examining how hormones and Exposure and Response Prevention (EX/RP) influence brain activ…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Neurostimulation and OCD, a MRI Study [NA]
A completed MRI-based neurostimulation study in Obsessive Compulsive Disorder.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Virtual Reality Exposure Therapy for Obsessive-Compulsive Disorder: Outpatients Trial [NA]
Clinical trial update for VR exposure therapy targeting Obsessive-compulsive disorder in outpatients, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: Accelerated rTMS Therapeutic Approach for Refractory Obsessive-Compulsive Disorder [NA]
This clinical trial update describes an accelerated rTMS approach being studied for refractory obsessive-compulsive disorder and notes that …
-
FDA approval · 2025-09-26FDA Approved: FLUOXETINE — Supplemental Application (NIVAGEN PHARMACEUTICALS, INC.)
FDA approves a supplemental application for fluoxetine hydrochloride from NIVAGEN Pharmaceuticals, enabling the marketing of a generic fluox…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: ZeroOCD: Learn to Overcome Contamination OCD With Your Smartphone [NA]
This update covers the ZeroOCD trial, a smartphone-based program intended to help people with obsessive-compulsive disorder manage contamina…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS [Phase 4]
A Phase 4 clinical trial evaluating naproxen sodium for treating OCD symptoms in children with PANDAS has been terminated.
-
FDA approval · 2025-09-24FDA Approved: PAROXETINE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals Inc. Paroxetine Original Application for a generic paroxetine product.
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Neurobehavioral Investigations of Approach Dynamics in the Ventral Striatum [NA]
A Baylor College of Medicine clinical trial update investigating neurobehavioral dynamics in the ventral striatum for Obsessive-Compulsive D…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Neuromodulation for a Novel OCD Biomarker and Treatment [NA]
A Boston University study is currently recruiting to assess a neuromodulation approach targeting a novel OCD biomarker as a potential treatm…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Project EMPOWER-OCD [Phase 1]
Clinical trial update for Project EMPOWER-OCD, a Phase 1 study addressing Obsessive-Compulsive Disorder, sponsored by Boston University Char…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Computerized Training for Individuals Diagnosed With Obsessive-Compulsive and Related Disorders [NA]
A Stanford University-sponsored clinical trial evaluating computerized training for individuals diagnosed with obsessive-compulsive and rela…
-
CLINICAL_TRIALS trial_result · 2025-09-09Clinical Trial Update: Transcranial Direct Current Stimulation Potentiation of Fear Extinction in OCD [NA]
A completed clinical trial investigating transcranial direct current stimulation to enhance fear extinction in obsessive-compulsive disorder…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Pharmacogenomics of Selective Serotonin Reuptake Inhibitor (SSRI)-Induced Behavioural Activation
A clinical trial update investigating genetic factors that influence SSRI-induced behavioral activation in patients with major depressive di…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Modification of Cerebral Activity of Obsessive Compulsive Disorder (OCD) Patients During Cognitive and Behavioral Therapy [NA]
This completed clinical trial examined changes in brain activity in obsessive-compulsive disorder patients during cognitive-behavioral thera…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: NAC for Treatment-Resistant OCD and Other Related Disorders [Phase 4]
Phase 4 clinical trial update for N-acetylcysteine in treatment-resistant obsessive-compulsive disorder; the study is currently active but n…
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Mental Health, Intellectual and Neurodevelopmental Disorder Detection With Artificial Intelligence Models
A clinical trial is evaluating artificial intelligence models to detect Autism Spectrum Disorder, Major Depressive Disorder and other mental…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Study of Dextromethorphan in OCD and Related Disorders [Phase 2]
Phase 2 clinical trial evaluating dextromethorphan for obsessive-compulsive disorder and related disorders; currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Efficacy of Nitrous Oxide in OCD: Pilot Study [Phase 2]
A Phase 2 pilot trial at Stanford University is evaluating nitrous oxide for obsessive-compulsive disorder and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Accelerated rTMS in Hospitalized Patients With OCD: a Feasibility and Mechanistic Study [NA]
This clinical trial update describes a feasibility and mechanistic study of accelerated repetitive transcranial magnetic stimulation (rTMS) …
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder [Phase 3]
Completed Phase 3 trial evaluating adjunctive troriluzule for obsessive-compulsive disorder, with results on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Online Exposure Therapy for Obsessive-Compulsive Disorder (OCD) Study [NA]
Completed clinical trial evaluating online exposure therapy for Obsessive-Compulsive Disorder, sponsored by the University of Miami.
-
CLINICAL_TRIALS research · 2025-08-18Clinical Trial Update: Phase II Adaptive Deep Brain Stimulation for Obsessive-Compulsive Disorder [NA]
This clinical trial update indicates a Phase II adaptive deep brain stimulation study for obsessive-compulsive disorder conducted by Baylor …